A woman, aged 45 years, who had been taking a drospirenone-containing hormonal contraceptive for “5 years”[1] was admitted to a hospital “with angina,”[2] which is “chest pain or discomfort you get when your heart muscle does not get enough blood.”[3] Doctors quickly realized that the woman was having a heart attack, and after a great many procedures and drug administrations, the woman was released “after 8 days,”[4] and “in a stable condition.”[5]
This woman’s doctors believed that “her use of ethinylestradiol/drospirenone was … related to the [heart attack],”[6] and eventually published an article on this in the medical journal Clinical and Applied Thrombosis/Hemostasis titled “Acute myocardial infarction due to oral contraceptive,” (May-June 2009).
Examples of oral contraceptives containing drospirenone are YAZ®, Yazmin®, Beyaz®, and Safyal®. Demonstrating the possible dangers to which these hormonal contraceptive can lead, this article may be used in a pharmaceutical lawsuit to illustrate the undue harm posed to users of these drugs, for these oral contraceptives are no more effective than oral contraceptives without drospirenone.
[1] “Acute Myocardial Infarction: Case Report.” Case Reports. Reactions Weekly 8 Aug 2009, No. 1264 © 2009 Adis Data Information BV; p. 17
[2] Ibid
[3] “Angina” MedlinePlus. National Library of Medicine. National Institutes of Health. Available at <http://www.nlm.nih.gov/medlineplus/angina.html> Page Updated 5 October 2012, Accessed 10 October 2012
[4] “Acute Myocardial Infarction: Case Report.” Case Reports. Reactions Weekly 8 Aug 2009, No. 1264 © 2009 Adis Data Information BV; p. 17
[5] Ibid
[6] Ibid
Comments